Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.

Mustafa GürbüzErman AkkuşAbdullah SakinSemiha UrvayAtike Gökçen DemiraySüleyman ŞahinTeoman ŞakalarCihan ErolMehmet Ali Nahit ŞendurAhmet Bilgehan ŞahinErdem ÇubukçuDeniz Can GüvenSaadettin KılıçkapYakup ErgünDoğan UncuNazım Serdar TurhalNecdet ÜskentHavva Yeşil ÇinkirAtakan DemirRamazan AcarNuri KaradurmuşSema TürkerMustafa AltınbaşMert KaraoğlanFiliz Çay Şenler

Published in: Tumori (2020)

Trastuzumab combination with intensified chemotherapy provides better OS in first-line treatment of HER2-positive advanced gastric cancer. Further large-scale studies should be performed in HER2-positive patients.

Keyphrases

end stage renal disease
neoadjuvant chemotherapy
metastatic breast cancer
locally advanced
epidermal growth factor receptor
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
lymph node
patient reported